history of disease, except an episode of malaria. She had been living in Italy for a few months. Proteinuria at dipstix was +++ and renal function was normal.
A few days after the visit in our center she presented to the Emergency Department because of acute renal failure (Serum Creatinine-SCr-was 1.8 mg/dl).
She was hospitalized in our Nephrology Department. Physical examination showed bilateral leg edema.
Laboratory examinations confirmed a severe nephrotic syndrome (proteinuria 16.8 g/day, serum albumin 2.3 g/dl, total serum proteins 4.8 g/dl). Renal function was worsening (SCr increased in few days from 1.8 mg/dl to 5.8 mg/dl). No monoclonal components were detected neither in serum nor in urine. IgA were 110 mg/dl, IgG 650 mg/dl, IgM 45 mg/dl. The patient underwent a renal biopsy, which showed 22 glomeruli, one with global sclerosis. Glomerular basement membranes were thin, as were the mesangial axes. No pathologic alterations could be detected as regards the interstitium and the vessels. Immunohistochemical examination was negative. Search for anti-phospholipase A2 receptors on renal tissue resulted negative at immunofluorescence.
Introduction
The typical manifestation of onset of Minimal change disease (MCD) is a pure nephrotic syndrome.
The nephropathy may respond rapidly to corticosteroids [1] , but may also show frequent relapses, which occur in 25%-30% of patients during corticosteroid tapering [1] . In these cortico dependent adult patients K-DIGO guidelines recommend a 8-12 weeks course treatment with Cyclophosphamide (CyF) 1 mg/kg/day [2] .
CyF is a nitrogen mustard belonging to alkylating drugs' group, which is known to have common early side effects, such as leukopenia and thrombocytopenia, bladder and mucosal toxicity, and also common late side effects, such as infertility or carcinogenesis.
A blue pigmentation of fingernail is not specifically reported in company product characteristics, even if nail discoloration and nail disorders are listed among the numerous side effects, and have only anecdotally been reported in the literature [3] [4] [5] .
Case Report
A 52-year-old Malagasy woman presented to our observation because of leg edema. She had no previous 1b 1a regimen of 3 methylprednisolone 750 mg pulses followed by corticosteroid 1 mg/kg/day (50 mg/day) was started.
Renal function normalized in 30 days. Proteinuria was 0.3 g/day at the 6 th week. Corticosteroid tapering was started after the 8 th week. Fourteen days later proteinuria was again 21 g/day and corticosteroids were increased to 1 mg/kg/day; full dose was maintained for a longer time (6 months). Proteinuria completely disappeared a few days after the increase in corticosteroid doses. Six months later, slower tapering of corticosteroids was started. Four months later, at a dose of prednisone 25/5 mg every other day, proteinuria relapsed again (2.1 g/ day).
The patient was then given CyF 2 mg/kg/day (100 mg/day). At day 15 th after the beginning of CyF she complained of her nails turning to a blue color (Figure 1a and Figure 1b) , which became complete and diffuse at day 30 th (Figure 2a and Figure 2b ). CyF was discontinued after 90 days. The discoloration of the patient's nails progressively disappeared and 5 months later her nails were normal again (Figure 3 ).
Discussion
The change of nail color with appearance of a bluegray pigmentation is reported in some clinical conditions, such as HIV [6, 7] , but it is much more frequently associated to some drugs, such as gefitinib [8] , sparfloxacin [9] , azidothymidine [10] , hydroxyurea [11] , imipramine [12] , minocycline [13, 14] .
